These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 9031482)

  • 1. Anticardiolipin antibodies and recurrent thromboembolism.
    Rance A; Emmerich J; Fiessinger JN
    Thromb Haemost; 1997 Jan; 77(1):221-2. PubMed ID: 9031482
    [No Abstract]   [Full Text] [Related]  

  • 2. Lipoprotein (a) and anticardiolipin antibodies as risk factors for vascular disease in rheumatoid arthritis.
    Seriolo B; Accardo S; Fasciolo D; Sulli A; Bertolini S; Cutolo M
    Thromb Haemost; 1995 Aug; 74(2):799-800. PubMed ID: 8585028
    [No Abstract]   [Full Text] [Related]  

  • 3. Recurrent thrombosis in patients with deep vein thrombosis and/or venous thromboembolism associated with anticardiolipin antibodies.
    de Godoy JM; de Godoy MF; Braile DM
    Angiology; 2006; 57(1):79-83. PubMed ID: 16444460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anticardiolipin antibodies as a risk factor for venous thromboembolism in a population-based prospective study.
    Runchey SS; Folsom AR; Tsai MY; Cushman M; McGovern PD
    Br J Haematol; 2002 Dec; 119(4):1005-10. PubMed ID: 12472581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anticardiolipin antibodies predict early recurrence of thromboembolism and death among patients with venous thromboembolism following anticoagulant therapy. Duration of Anticoagulation Study Group.
    Schulman S; Svenungsson E; Granqvist S
    Am J Med; 1998 Apr; 104(4):332-8. PubMed ID: 9576405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of recurrent venous thromboembolism or bleeding in relation to thrombophilic risk factors in patients receiving ximelagatran or placebo for long-term secondary prevention of venous thromboembolism.
    Wåhlander K; Eriksson H; Lundström T; Billing Clason S; Wall U; Nyström P; Wessman P; Schulman S;
    Br J Haematol; 2006 Apr; 133(1):68-77. PubMed ID: 16512831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anticardiolipin antibodies in acute venous thromboembolism.
    Bongard O; Reber G; Bounameaux H; de Moerloose P
    Thromb Haemost; 1992 Jun; 67(6):724. PubMed ID: 1509416
    [No Abstract]   [Full Text] [Related]  

  • 8. Anticoagulation for thromboembolism and anticardiolipin-antibody positivity in Lemierre disease.
    Kaushik P; Lampman JH; Kaushik R
    Am J Med; 2008 Apr; 121(4):e11; author reply e13. PubMed ID: 18374669
    [No Abstract]   [Full Text] [Related]  

  • 9. A comparison of lupus anticoagulant-positive patients with clinical picture of antiphospholipid syndrome and those without.
    Pengo V; Biasiolo A; Gresele P; Marongiu F; Erba N; Veschi F; Ghirarduzzi A; Barcellona D; Tripodi A
    Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):e309-10. PubMed ID: 18029906
    [No Abstract]   [Full Text] [Related]  

  • 10. The obstetric antiphospholipid syndrome.
    Derksen RH; de Groot PG
    J Reprod Immunol; 2008 Jan; 77(1):41-50. PubMed ID: 17239960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence of thromboembolic events in patients with primary Sjögren's syndrome.
    Haga HJ; Jacobsen EM; Peen E
    Scand J Rheumatol; 2008; 37(2):127-9. PubMed ID: 18415770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticardiolipin antibodies in women with recurrent abortion.
    Daboubi MK
    East Mediterr Health J; 2001; 7(1-2):95-9. PubMed ID: 12596957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antiphospholipid sydrome--recurrent thrombosis and foetal loss due to antiphospholipid antibodies].
    Elezović I; Matijević-Aleksić N; Rolović Z
    Srp Arh Celok Lek; 1994; 122(5-6):179-81. PubMed ID: 17977423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticardiolipin antibodies and thromboembolism after BMT.
    Qasim W; Gerritsen B; Veys P
    Bone Marrow Transplant; 1998 Apr; 21(8):845-7. PubMed ID: 9603414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombophilic profile of climacteric and menopausal women with venous thromboembolism.
    Margarido PF; D'Amico E; Bagnoli VR; Fonseca AM; Halbe HW; Pinotti JA
    Climacteric; 2002 Mar; 5(1):87-9. PubMed ID: 11974563
    [No Abstract]   [Full Text] [Related]  

  • 16. Anticardiolipin antibodies and osteonecrosis of the femoral head.
    Korompilias AV; Gilkeson GS; Ortel TL; Seaber AV; Urbaniak JR
    Clin Orthop Relat Res; 1997 Dec; (345):174-80. PubMed ID: 9418637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of periprocedural neurological deficit in carotid stenting with increased anticardiolipin antibodies.
    Steiner S; Sadushi R; Bartok A; Hammer A; Quehenberger P; Mannhalter C; Koppensteiner R; Minar E; Kopp CW
    Thromb Res; 2009 Apr; 123(6):827-31. PubMed ID: 18817951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The clinical significance of anti-prothrombin antibodies for risk assessment of thromboembolism in patients with lupus anticoagulant.
    Sailer T; Vormittag R; Zoghlami C; Koder S; Quehenberger P; Male C; Pabinger I
    Thromb Res; 2007; 120(2):295-302. PubMed ID: 17328943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular dementia and anticardiolipin antibodies.
    de Godoy JM; de Godoy MR; Cipulo JP; Tognola VA
    Med Sci Monit; 2005 Sep; 11(9):CR430-3. PubMed ID: 16127362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of the duration of anticoagulation and other risk factors on the recurrence of venous thromboembolisms. Duration of Anticoagulation Study Group.
    Schulman S
    Wien Med Wochenschr; 1999; 149(2-4):66-9. PubMed ID: 10378327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.